|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/355 | |
| A61P 3/00 | |||
| A61P 25/28 |
| (11) | Patento numeris | 2471530 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12162555.2 |
| Europos patento paraiškos padavimo data | 2006-06-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-07-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 686826 P | 2005-06-01 | US | |
| 701815 P | 2005-07-21 | US | |
| 776028 P | 2006-02-22 | US |
| (72) |
Miller, Guy M.,, US
Hecht, Sidney M.,, US
|
| (73) |
Edison Pharmaceuticals, Inc.,
350 North Bernardo Avenue, Mountain View, CA 94043,
US
|
| (54) | REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS |
| REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS |